Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Oncologist|January 3, 2012
Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximabRaymond C Wadlow, Aram F Hezel, Thomas A Abrams, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2012
Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapyNils D Arvold, Christopher G Willett, Carlos Fernandez-del Castillo, et al.
Investigational New Drugs|January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancerLipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.
Cancer|February 7, 2014
Mutational analysis and clinical correlation of metastatic colorectal cancerAndrea L Russo, Darrell R Borger, Jackie Szymonifka, et al.
Gastroenterology|October 27, 2025
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal AdenocarcinomaAimee L Lucas, Diane M Simeone, Bryson W Katona, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinomaTheodore S Hong, David P Ryan, Darrell R Borger, et al.
Nature|October 23, 2009
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A Barbie, Pablo Tamayo, Jesse S Boehm, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2024
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk IndividualsGeorge Zogopoulos, Ido Haimi, Shenin A Sanoba, et al.
Pageof 2